Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis - ScienceDirect
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease | FibroGen, Inc.
The Roxadustat Chronicles: A Two-Article NephJC — NephJC
Roxadustat in phase III clinical trials. | Download Scientific Diagram
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan | American Society of Nephrology
Roxadustat in clinical trials with CRP. | Download Scientific Diagram
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia | American Society of Nephrology
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Frontiers | Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis | Medicine
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Completed Phase 2 and 3 Studies of Roxadustat (FG-4592), Vadadustat... | Download Table
Roxadustat Treatment for Anemia in Dialysis | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og:image" content ...
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD | American Society of Nephrology
IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future? | HTML
Roxadustat in clinical trials with CRP. | Download Scientific Diagram
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease | FibroGen, Inc.
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study | American Society of Nephrology
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Phase 3 clinical trials of Roxadustat. | Download Scientific Diagram
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
The Next Big Biotech Blow-Up (NASDAQ:FGEN) | Seeking Alpha
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study | American Society of Nephrology
The Roxadustat Chronicles: A Two-Article NephJC — NephJC
Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat | Medicine
Key milestones in the development of roxadustat for the treatment of... | Download Scientific Diagram
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease | FibroGen, Inc.
